OneOme, which was co-developed and exclusively licensed from Mayo Clinic, helps providers make personalized prescription decisions for patients, which may result in more effective medications and fewer side effects. OneOme’s RightMed® comprehensive test is a pharmacogenomic test that analyzes a person’s DNA to predict how he or she is likely to respond to a medication — giving providers useful information in inform their prescription decisions